-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Initiates Coverage On Claritev with Overweight Rating, Announces Price Target of $28

Benzinga·04/24/2026 13:44:06
Listen to the news
Barclays analyst Glen Santangelo initiates coverage on Claritev (NYSE:CTEV) with a Overweight rating and announces Price Target of $28.